Protara Therapeutics Q1 2026 Earnings EPS Beats Estimates Amid Continued Pipeline Progress CMBM Q3 2024 Earnings NarrowerthanExpected Loss Signals Operational Discipline GTLS Q1 2026 Earnings Massive EPS Miss Highlights Operational Challenges MMSI Q1 2026 Earnings EPS Surpasses Estimates by 1068 LMRI Q1 2026 Earnings EPS Surges Past Expectations by 45 Stock Edges Lower RSG Q1 2026 Earnings EPS Beat Drives Modest Stock Uptick